Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study

BACKGROUND: Statins are increasingly prescribed to prevent cardiovascular disease (CVD) in asymptomatic individuals. Yet, it is unknown whether those at higher CVD risk – i.e. individuals in lower socio-economic position (SEP) – are adequately reached by this high-risk strategy. We aimed to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallach-Kildemoes, Helle, Diderichsen, Finn, Krasnik, Allan, Lange, Theis, Andersen, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444315/
https://www.ncbi.nlm.nih.gov/pubmed/22863326
http://dx.doi.org/10.1186/1471-2458-12-610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444315/
https://www.ncbi.nlm.nih.gov/pubmed/22863326
http://dx.doi.org/10.1186/1471-2458-12-610

Ejemplares similares